Papeles volátiles (Small caps)
Re: Papeles volátiles (Small caps)
juan04 escribió:
hola alrosario,la estube mirando y esta en 9,25 si los rompe si va a 9,26.
nooooooooooo!!! un groso...
Re: Papeles volátiles (Small caps)
Juan, decime què te parece SKBI
Re: Papeles volátiles (Small caps)
dragon escribió:es que estaba indecisa , capoooooooo
jajaja,en coin hay carrera .
http://stockcharts.com/h-sc/ui?s=COIN&p ... 1058921495
juan04 escribió:ferbar,quien es Len Bogner.?
El analista que escibrió el informe sobre RPC.
Re: Papeles volátiles (Small caps)
Yo le creo a Len Bogner.
Re: Papeles volátiles (Small caps)
es que estaba indecisa , capoooooooo 
Re: Papeles volátiles (Small caps)
adentro FBP

Re: Papeles volátiles (Small caps)
que carajo ALXA 
Re: Papeles volátiles (Small caps)
barabanki escribió:No es demasiado obvio lo de SNSS?
La bajan con 87000 papeles como si se fuera a fundir.
Ayer anduvo negociando los 13 palos.
Señal de que algo bueno llega.
Giles.
Re: Papeles volátiles (Small caps)
afuera ASTM 
Re: Papeles volátiles (Small caps)
ojo con las grandotas tambien. PBR, MGM y C a punto de romper
Re: Papeles volátiles (Small caps)
si achica un poco GNVC al inicio esta linda para un intraday, vamos a ver.
esta saturada, pero hay una noticia
Press Release Source: GenVec, Inc. On Wednesday December 29, 2010, 7:14 am EST
GAITHERSBURG, Md., Dec. 29, 2010 /PRNewswire/ -- GenVec, Inc. (Nasdaq:GNVC - News) today announced that the company will be working with Merial to develop and commercialize GenVec's proprietary vaccine technology for use against foot-and-mouth disease (FMD). Merial is the leading FMD vaccine producer in the world, with leading positions in all key markets. Under the agreement, Merial will be responsible for all costs related to the development and commercialization of FMD vaccines developed through the collaboration. GenVec will receive development milestones and royalties on sales
esta saturada, pero hay una noticia
Press Release Source: GenVec, Inc. On Wednesday December 29, 2010, 7:14 am EST
GAITHERSBURG, Md., Dec. 29, 2010 /PRNewswire/ -- GenVec, Inc. (Nasdaq:GNVC - News) today announced that the company will be working with Merial to develop and commercialize GenVec's proprietary vaccine technology for use against foot-and-mouth disease (FMD). Merial is the leading FMD vaccine producer in the world, with leading positions in all key markets. Under the agreement, Merial will be responsible for all costs related to the development and commercialization of FMD vaccines developed through the collaboration. GenVec will receive development milestones and royalties on sales
¿Quién está conectado?
Usuarios navegando por este Foro: Ahrefs [Bot], Amazon [Bot], Baidu [Spider], Bing [Bot], bohemio33, CARLOS GONZALEZ, choke, come60, davinci, elcipayo16, Fabian66, Gogui, Gon, Google [Bot], Itzae77, j3bon, mp01, napolitano, redtoro, Semrush [Bot] y 1026 invitados